Biologics vs Biosimilars:Research and Development in Pharma

Microbioz India, July , 2019 Issue

Cover Story : "Biologics vs Biosimilars:Research and Development in Pharma"

Biologics vs Biosimilars:Research and Development in Pharma

Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the July 2019 edition of Microbioz India magazine, supported by the cover story entitled “Biologics vs Biosimilars : Research and Development in Pharma” a review study on comperative study of Biosimilars and Biologics.A biosimilar is exactly what its name implies — it is a biologic that is “similar” to another biologic medicine (known as a reference product) which is already licensed by the U.S. Food and Drug Administration (FDA).

Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. In approving biosimilars, the FDA may require that manufacturers conduct a clinical study (or studies) sufficient to establish safety, purity or potency in one or more uses for which the reference product is licensed and the biosimilar seeks licensure.

Added to this, the current edition has a special featured guest article entitled “Take a look at Blood with analysis machines ” by maxon precision motor India Pvt Ltd. Includes product description with Blood analysis.Our blood is a fascinating fluid it transports oxygen and nutrients, fends off foreign objects and closes wounds. At least in normal cases some people, however, suffer from coagulation disorders. These cases are unpleasant for the patient and can have severe consequences – or even lead to death. This is why early detection of a blood disorder and the hunt for a cure are so important. This requires a lot of testing. We have the latest market research news and insightful product launches inside, collected from worldwide sources to keep you updated with what is going on in the industry.


Controlled Rate Freezing of Biological Samples

SP Scientific introduces the new BioCool V40 - a robust and reliable mechanically refrigerated 1.5-litre system designed for controlled rate freezing of biological materials including blood, embryos and tissue samples.

Multi Wavelength Instrument Improves Nanoparticle Analysis Specificity

Analytik has launched the next generation ZetaView® QUATT, with a multi-wavelength video tracking microscope for rapid analysis of size, concentration, fluorescence, electrophoretic mobility and sub-populations of individual nanoparticles.

Metrohm Autolab Partners with Arbin Instruments to Create an Integrated Solution for Battery Research

Metrohm Autolab and Arbin Instruments have combined their decades of experience to launch a new Electrochemical Impedance Spectroscopy (EIS) solution that can easily be integrated into any battery testing program.

EAF2000 Advances Complex Charged Molecule Studies

Postnova Analytics reports on growing use of its pioneering EAF2000 system to separate and characterize complex proteins, antibodies and viruses as well as charged nanoparticles, colloids and polymers.